Iktos

Iktos is a company that uses artificial intelligence (AI) and robotics to streamline the process of drug discovery.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

Generative AI in Drug Discovery, Autonomous Lab Technology, AI-Driven Synthesis Automation

About Us

Iktos specializes in transforming drug discovery through advanced AI and robotics. Their platform integrates generative AI for molecular design, retrosynthesis planning, and automated synthesis, significantly speeding up the process of developing new treatments.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies